In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections |
| |
Authors: | Goldstein Ellie J C Citron Diane M Warren Yumi A Tyrrell Kerin L Merriam C Vreni Fernandez Helen T |
| |
Institution: | R. M. Alden Research Laboratory, Santa Monica, CA 90404, USA. ejcgmd@aol.com |
| |
Abstract: | Tests of dalbavancin's in vitro activity against 209 aerobic and 120 anaerobic isolates from pretreatment diabetic foot infections showed an MIC(90) of < or =0.125 microg/ml against methicillin-susceptible Staphylococcus aureus (MSSA), methicillin-resistant S. aureus (MRSA), and 120 anaerobes (Clostridium perfringens, other clostridia, Peptoniphilus asaccharolyticus, Finegoldia magna, and Anaerococcus prevotii), compared to respective MIC(90)s for MSSA and MRSA of 0.5 and 1 microg/ml for vancomycin, 4 and 4 microg/ml for linezolid, 0.5 and 0.5 microg/ml for daptomycin, and 0.25 and >8 microg/ml for clindamycin. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|